These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36933173)

  • 1. Digoxin and Standard-of-Care Therapy for Heart Failure Patients with COVID-19: Analysis of Data from the US Military Health System (MHS) Data Repository.
    Banaag AL; Pollard HB; Koehlmoos TP
    Drugs Real World Outcomes; 2023 Jun; 10(2):299-307. PubMed ID: 36933173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and predictors of digoxin utilization among heart failure patients with reduced ejection fraction in Qatar.
    Rahhal AA; Awaisu A; Tawengi KM; AbuYousef S; Mekideche L
    Int J Clin Pharm; 2017 Oct; 39(5):1070-1083. PubMed ID: 28823072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure: Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry.
    Patel N; Ju C; Macon C; Thadani U; Schulte PJ; Hernandez AF; Bhatt DL; Butler J; Yancy CW; Fonarow GC
    JACC Heart Fail; 2016 May; 4(5):348-56. PubMed ID: 26874392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin use in contemporary heart failure with reduced ejection fraction: an analysis from the Swedish Heart Failure Registry.
    Kapelios CJ; Lund LH; Benson L; Dahlström U; Rosano GMC; Hauptman PJ; Savarese G
    Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 8(8):756-767. PubMed ID: 34921603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of digoxin on risk of death in heart failure patients treated with b-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry.
    Migaj J; Kałużna-Oleksy M; Nessler J; Opolski G; Crespo-Leiro MG; Maggioni AP; Grajek S; Ponikowski P; Drożdż J; Straburzyńska-Migaj E
    Kardiol Pol; 2018; 76(7):1064-1072. PubMed ID: 29476617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
    Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
    [No Abstract]   [Full Text] [Related]  

  • 7. Utilization of antiobesity medications within the Military Health System.
    Neuman T; Corrado R; Banaag A; Koehlmoos TP
    Obesity (Silver Spring); 2024 Aug; ():. PubMed ID: 39089987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common cardiac medications potently inhibit ACE2 binding to the SARS-CoV-2 Spike, and block virus penetration and infectivity in human lung cells.
    Caohuy H; Eidelman O; Chen T; Liu S; Yang Q; Bera A; Walton NI; Wang TT; Pollard HB
    Sci Rep; 2021 Nov; 11(1):22195. PubMed ID: 34773067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial.
    Ambrosy AP; Bhatt AS; Stebbins AL; Wruck LM; Fudim M; Greene SJ; Kraus WE; O'Connor CM; Piña IL; Whellan DJ; Mentz RJ
    Am Heart J; 2018 May; 199():97-104. PubMed ID: 29754673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digoxin is associated with worse outcomes in patients with heart failure with reduced ejection fraction.
    Zhou J; Cao J; Jin X; Zhou J; Chen Z; Xu D; Yang X; Dong W; Li L; Fan Y; Chen L; Zhong Q; Fu M; Hu K; Ge J;
    ESC Heart Fail; 2020 Feb; 7(1):138-146. PubMed ID: 31994361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is foxglove effective in heart failure?
    Chaggar PS; Shaw SM; Williams SG
    Cardiovasc Ther; 2015 Aug; 33(4):236-41. PubMed ID: 25925484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin Initiation and Outcomes in Patients with Heart Failure (HFrEF and HFpEF) and Atrial Fibrillation.
    Singh S; Moore H; Karasik PE; Lam PH; Wopperer S; Arundel C; Tummala L; Anker MS; Faselis C; Deedwania P; Morgan CJ; Zeng Q; Allman RM; Fonarow GC; Ahmed A
    Am J Med; 2020 Dec; 133(12):1460-1470. PubMed ID: 32603789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
    Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
    Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin and Outcomes in Patients with Heart Failure and Preserved Ejection Fraction (HFpEF) Patients: A Systematic Review and Meta- Analysis.
    Hashemi-Shahri SH; Aghajanloo A; Ghavami V; Arasteh O; Mohammadpour AH; Reiner Ž; Sahebkar A
    Curr Drug Targets; 2023; 24(2):191-200. PubMed ID: 36065922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Use of Digitalis: A State of the Art Review.
    Whayne TF
    Am J Cardiovasc Drugs; 2018 Dec; 18(6):427-440. PubMed ID: 30066080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of Digoxin among Hospitalized Older Patients with Heart Failure and Atrial Fibrillation in Thailand: Prevalence, Associated Factors, and Clinical Outcomes.
    Singkham N; Wongsalap Y; Poolpun D; Phetnoo S; Somkhon C
    Ann Geriatr Med Res; 2021 Dec; 25(4):260-268. PubMed ID: 34958732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction.
    Abdul-Rahim AH; Shen L; Rush CJ; Jhund PS; Lees KR; McMurray JJV;
    Eur J Heart Fail; 2018 Jul; 20(7):1139-1145. PubMed ID: 29493058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin, mortality, and cardiac hospitalizations in patients with atrial fibrillation and heart failure with reduced ejection fraction and atrial fibrillation: An AF-CHF analysis.
    Elayi CS; Shohoudi A; Moodie E; Etaee F; Guglin M; Roy D; Khairy P;
    Int J Cardiol; 2020 Aug; 313():48-54. PubMed ID: 32320783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications.
    Stolfo D; Uijl A; Vedin O; Strömberg A; Faxén UL; Rosano GMC; Sinagra G; Dahlström U; Savarese G
    JACC Heart Fail; 2019 Jun; 7(6):505-515. PubMed ID: 31146874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.